Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Breuning

Showing results (331-340 of 391) with videos related to

Pageof 40
Sort By:
Human Genetics|October 28, 2008
Identification of copy number variants associated with BPES-like phenotypesAntoinet C J Gijsbers, Barbara D'haene, Yvonne Hilhorst-Hofstee, et al.
Frontiers in Aging Neuroscience|March 15, 2021
The Listening Network and Cochlear Implant Benefits in Hearing-Impaired AdultsChris J James, Petra L Graham, Frank A Betances Reinoso, et al.
American Journal of Human Genetics|October 27, 1997
A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2)B Veldhuisen, J J Saris, S de Haij, et al.
European Journal of Human Genetics : EJHG|November 11, 2010
The clinical spectrum of complete FBN1 allele deletionsYvonne Hilhorst-Hofstee, Ben C J Hamel, Joke B G M Verheij, et al.
Clinical Genetics|May 22, 2010
X-chromosome duplications in males with mental retardation: pathogenic or benign variants?A C J Gijsbers, N S den Hollander, A T J M Helderman-van de Enden, et al.
Plos One|May 11, 2012
Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriersKai Hang Yiu, Douwe E Atsma, Victoria Delgado, et al.
Neurobiology of Disease|October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]H M Mitchison, D J Bernard, N D Greene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma familiesFemke A de Snoo, D Timothy Bishop, Wilma Bergman, et al.
Familial Cancer|March 15, 2016
Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registryHans F A Vasen, Mary E Velthuizen, Jan H Kleibeuker, et al.
Kidney International|April 12, 2000
Location of mutations within the PKD2 gene influences clinical outcomeN Hateboer, B Veldhuisen, D Peters, et al.
Pageof 40

Showing results (331-340 of 391) with videos related to

Sort By:
Pageof 40
Human Genetics|October 28, 2008
Identification of copy number variants associated with BPES-like phenotypesAntoinet C J Gijsbers, Barbara D'haene, Yvonne Hilhorst-Hofstee, et al.
Frontiers in Aging Neuroscience|March 15, 2021
The Listening Network and Cochlear Implant Benefits in Hearing-Impaired AdultsChris J James, Petra L Graham, Frank A Betances Reinoso, et al.
American Journal of Human Genetics|October 27, 1997
A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2)B Veldhuisen, J J Saris, S de Haij, et al.
European Journal of Human Genetics : EJHG|November 11, 2010
The clinical spectrum of complete FBN1 allele deletionsYvonne Hilhorst-Hofstee, Ben C J Hamel, Joke B G M Verheij, et al.
Clinical Genetics|May 22, 2010
X-chromosome duplications in males with mental retardation: pathogenic or benign variants?A C J Gijsbers, N S den Hollander, A T J M Helderman-van de Enden, et al.
Plos One|May 11, 2012
Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriersKai Hang Yiu, Douwe E Atsma, Victoria Delgado, et al.
Neurobiology of Disease|October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]H M Mitchison, D J Bernard, N D Greene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma familiesFemke A de Snoo, D Timothy Bishop, Wilma Bergman, et al.
Familial Cancer|March 15, 2016
Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registryHans F A Vasen, Mary E Velthuizen, Jan H Kleibeuker, et al.
Kidney International|April 12, 2000
Location of mutations within the PKD2 gene influences clinical outcomeN Hateboer, B Veldhuisen, D Peters, et al.
Pageof 40